Search for Clinical Trial Results
Lymphoma, B-Cell, Marginal Zone - 25 Studies Found
Status | Study |
Completed |
Study Name: Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori Condition: Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive Date: 2010-12-20 Interventions: Drug: Rabeprazole Sodium The following 3 drugs are taken o |
Completed |
Study Name: Velcade in MALT Lymphoma Patients Condition: MALT Lymphoma Date: 2006-09-07 Interventions: Drug: Bortezomib (Velcade) |
Completed |
Study Name: Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL) Condition: Marginal Zone B-cell Lymphoma Date: 2010-07-15 Interventions: Drug: Everolimus Everolimus (tablets, 5 mg) is given orally at the dose of 10 mg/day from day 1 to day 2 |
Active, not recruiting |
Study Name: Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma Condition: Marginal Zone B-cell Lymphoma Date: 2016-07-26 Interventions: Drug: Bendamustine and Rituximab |
Terminated |
Study Name: Gemcitabine for Marginal Zone Lymphoma Condition:
Date: 2006-06-14 Interventions: Drug: gemcitabine D1 and 8, Gemcitabine 1250mg/m2 + NS 100ml MIV over 30min, every 3 weeks |
Active, not recruiting |
Study Name: Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment Condition: Marginal Zone Lymphoma of Ocular Adnexal Date: 2013-03-26 Interventions: Drug: Doxycycline All enrolled patients will be treated with doxycycline 100 mg bid daily, orally, for f |
Active, not recruiting |
Study Name: 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma Condition: Relapsed or Refractory Marginal Zone B-cell Lymphoma Date: 2012-09-04 Interventions: Drug: 131I-rituximab |
Completed |
Study Name: Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome Condition: Gastric MALT Lymphoma Date: 2006-05-17 Interventions: Drug: Omeprazole, Amoxicillin, Clarithromycin |
Active, not recruiting |
Study Name: Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma Condition:
Date: 2013-10-29 Interventions: Drug: ibrutinib |
Terminated |
Study Name: Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma Condition:
Date: 2010-02-11 Interventions:
|